IRIS
RAMELLA, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 11.255
NA - Nord America 3.066
EU - Europa 2.022
SA - Sud America 550
AF - Africa 85
OC - Oceania 16
Totale 16.994
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 8.958
US - Stati Uniti d'America 2.932
CN - Cina 1.088
IT - Italia 1.042
HK - Hong Kong 590
BR - Brasile 393
VN - Vietnam 260
FR - Francia 218
GB - Regno Unito 213
DE - Germania 181
IN - India 96
NL - Olanda 95
CA - Canada 59
EE - Estonia 57
AR - Argentina 56
FI - Finlandia 49
ID - Indonesia 44
MX - Messico 41
ZA - Sudafrica 31
BD - Bangladesh 29
EC - Ecuador 29
TR - Turchia 28
IQ - Iraq 25
UA - Ucraina 20
CO - Colombia 19
ES - Italia 18
AT - Austria 17
JP - Giappone 17
CZ - Repubblica Ceca 16
SE - Svezia 16
CL - Cile 15
PL - Polonia 14
SA - Arabia Saudita 14
AU - Australia 13
PH - Filippine 13
RU - Federazione Russa 13
PE - Perù 12
PK - Pakistan 12
TN - Tunisia 10
VE - Venezuela 10
MA - Marocco 9
RO - Romania 9
KZ - Kazakistan 8
UZ - Uzbekistan 8
EG - Egitto 7
DO - Repubblica Dominicana 6
KE - Kenya 6
LT - Lituania 6
NP - Nepal 6
UY - Uruguay 6
BO - Bolivia 5
CH - Svizzera 5
CR - Costa Rica 5
HU - Ungheria 5
MY - Malesia 5
TH - Thailandia 5
TW - Taiwan 5
AZ - Azerbaigian 4
DZ - Algeria 4
GT - Guatemala 4
IL - Israele 4
JO - Giordania 4
OM - Oman 4
PY - Paraguay 4
BE - Belgio 3
BG - Bulgaria 3
GE - Georgia 3
IE - Irlanda 3
NI - Nicaragua 3
PA - Panama 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
CM - Camerun 2
DK - Danimarca 2
GR - Grecia 2
IR - Iran 2
JM - Giamaica 2
LB - Libano 2
LY - Libia 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
SN - Senegal 2
AE - Emirati Arabi Uniti 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
BZ - Belize 1
CY - Cipro 1
ET - Etiopia 1
GA - Gabon 1
GF - Guiana Francese 1
GP - Guadalupe 1
HN - Honduras 1
Totale 16.967
Salva come PNG Salva come JPEG
Città #
San Jose 1.136
Singapore 770
Rome 661
Ashburn 597
Hong Kong 522
Hefei 394
Beijing 262
Dallas 215
Boardman 197
Lauterbourg 191
London 173
Shanghai 138
Munich 104
Ho Chi Minh City 98
Council Bluffs 85
Los Angeles 63
Hanoi 58
Amsterdam 43
New York 37
San Francisco 36
Santa Clara 36
São Paulo 30
Turku 28
Pune 27
Washington 26
Seattle 25
Milan 24
Naples 23
Toronto 23
Helsinki 21
Chicago 20
Mexico City 17
Brooklyn 16
Chennai 14
Montreal 14
Orem 13
Quito 13
Atlanta 12
Boston 12
Brno 12
Haiphong 12
Johannesburg 12
Rio de Janeiro 12
Sona 11
Tokyo 11
Charlotte 10
Frankfurt am Main 10
Lima 10
Nuremberg 10
Stockholm 10
Warsaw 10
West Jordan 10
Bogotá 9
Jakarta 9
Palermo 9
Phoenix 9
Biên Hòa 8
Bologna 8
Curitiba 8
Da Nang 8
Guayaquil 8
Hải Dương 8
Manaus 8
Manchester 8
St Louis 8
Tashkent 8
Baghdad 7
Brasília 7
Buenos Aires 7
Dhaka 7
Florence 7
Guangzhou 7
Ankara 6
Belo Horizonte 6
Denver 6
Guarulhos 6
Hanover 6
Nairobi 6
New Delhi 6
Redmond 6
Santiago 6
Buffalo 5
Dammam 5
Hangzhou 5
Jinan 5
Marseille 5
Melbourne 5
Montevideo 5
Rocca di Papa 5
Salvador 5
San José 5
Santo André 5
Vicenza 5
Amman 4
Bangkok 4
Brescia 4
Cascina 4
Haikou 4
Hortolândia 4
Itajaí 4
Totale 6.614
Salva come PNG Salva come JPEG
Nome #
18F-choline PET/CT driven salvage radiotherapy in prostate cancer patients: up-date analysis with 5-year median follow-up 334
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium 322
Deep pathomics: A new image-based tool for predicting response to treatment in stage III non-small cell lung cancer 276
NEW TECHNOLOGIES IN RADIOTHERAPY FOR PROSTATE CANCER: FEASIBILITY, DOSIMETRIC ASPECTS AND CLINICAL RESULTS IN PATIENTS WITH AT LEAST 5-YEAR FOLLOW-UP 250
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung) 244
The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group 229
A bio-imaging signature as a predictor of clinical outcomes in locally advanced pancreatic cancer 229
A new three-dimensional conformal radiotherapy (3DCRT) technique for large breast and/or high body mass index patients: evaluation of a novel fields assessment aimed to reduce extra–target-tissue irradiation 228
Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial 227
Advances in pre-treatment evaluation of pancreatic ductal adenocarcinoma: a narrative review 226
RadioPathomics: Multimodal Learning in Non-Small Cell Lung Cancer for Adaptive Radiotherapy 225
Repeated courses of radiation treatment in an HER2-positive breast cancer patient with diffuse brain metastases: A case report 224
QUALITY ASSURANCE FOR CLINICAL PRACTICE IN CERVICAL CANCER BRACHYTHERAPY WITH IR-192 SOURCE: IN VIVO DOSIMETRY WITH QED DIODES 218
Ten years experience with breast reconstruction after salvage mastectomy in previously irradiated patients: analysis of outcomes, satisfaction and well-being 218
Exploring Deep Pathomics in Lung Cancer 217
Implementation of a voluntary deep inspiration breath hold technique (vDIBH) using BrainLab ExacTrac infrared optical tracking system. 215
Estimating the value of surgical clips for target volume delineation in external beam partial breast radiotherapy 214
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 213
Exploring Negated Entites for Named Entity Recognition in Italian Lung Cancer Clinical Reports 212
A morphing technique to estimate lung cancer deformation due to breathing in radiotherapic treatment 212
Radiotherapy for pain relief from bone metastases during Coronavirus (COVID-19) pandemic 211
Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy 211
Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E2-RADIatE OligoCare cohort 210
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 208
Radiotherapy for HER 2 Positive Brain Metastases: Urgent Need for a Paradigm Shift 205
Clinical results of stereotactic ablative radiotherapy in the treatment of liver metastases 205
Preventing Cardiotoxicity in Personalized Breast Irradiation 199
Combination of novel systemic agents and radiotherapy for solid tumors - part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy. 199
Histologic transformation to small-cell lung cancer following gefitinib and radiotherapy in a patient with pulmonary adenocarcinoma. 198
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 196
Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging 190
The role of multiparametric magnetic resonance imaging in the diagnosis of local recurrence after radical prostatectomy and before salvage radiotherapy 187
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 154
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center Experience 146
Ablative Five-Fraction Stereotactic Radiotherapy in Elderly Patients with Pancreatic Cancer: A Single Institution Experience 140
42P Radiation induced pneumonitis in the era of the COVID-19 pandemic: Artificial intelligence for differential diagnosis 139
A deep learning approach for overall survival prediction in lung cancer with missing values 136
Long term results of a prospective phase 2 study on volume de-escalation in neoadjuvant chemoradiotherapy of rectal cancer 134
A cast of shadow on adjuvant radiotherapy for prostate cancer: A critical review based on a methodological perspective. 130
Early GLS changes detection after chemoradiation in locally advanced non-small cell lung cancer (NSCLC) 128
Novel Skin Toxicity of Epidermal Growth Factor Receptor Inhibitors: A Case of Intertrigo-Like Eruption in a Patient with Metastatic Colorectal Cancer Treated with Cetuximab 127
The impact of intensified staging and combined therapies in locally advanced pancreatic cancer: a secondary analysis of prospective studies 127
CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis 126
Deep Reinforcement Learning for Fractionated Radiotherapy in Non-Small Cell Lung Carcinoma 125
Concurrent radiotherapy with palbociclib or ribociclib for metastatic breast cancer patients: preliminary assessment of toxicity 125
Radiation-induced pneumonitis in the era of the covid-19 pandemic: artificial intelligence for differential diagnosis 125
Evaluating GANs in Medical Imaging 122
Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer 122
Prospective study of cetuximab and gemcitabine in combination with radiation therapy: feasibility and efficacy in locally advanced pancreatic head cancer 121
MR imaging of rectal cancer before and after chemoradiation therapy 119
Breast Volume Is a Predictor of Higher Heart Dose in Whole-Breast Supine Free-Breathing Volumetric-Modulated Arc Therapy Planning 118
Beams arrangement in non small-cell lung cancer (NSCLC) according to PTV and dosimetric parameters predictive of pneumonitis 117
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 117
Laparoscopic total mesorectal excision (L-TME) for rectal cancer surgery: Does elective diverting ileostomy really protect? An observational retrospective cohort study 116
Factors predicting pathological response to neoadjuvant chemoradiotherapy in rectal cancer: The experience of a single institution with 269 patients (STONE-01) 116
LPS AND RADIATION-INDUCED GUT PERMEABILITY DAMAGE: FOCUS ON THE POTENTIAL BENEFICIAL EFFECT OF GRAPE SEED EXTRACT 112
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study 111
The psychological impact of the covid-19 pandemic on radiotherapy cancer patients 110
How I Treat Localized Soft Tissue Sarcomas: Update on Diagnosis, Risk Stratification, and Treatment 110
Application of a practical method for the isocenter point in vivo dosimetry by a transit signal 110
Can we prevent COVID-19 from causing victims among uninfected cancer patients? 108
A Multimodal Ensemble Driven by Multiobjective Optimisation to Predict Overall Survival in Non-Small-Cell Lung Cancer 106
Different biliary microbial flora influence type of complications after pancreaticoduodenectomy: a single center retrospective analysis 105
Design and evaluation of a methodology to perform personalized visual biofeedback for reducing respiratory amplitude in radiation treatment 105
Chemoradiation for stage III non-small cell lung cancer 103
A clinical score, including biohumoral parameters, is a useful pretest index to discriminate pulmonary infections from radiation damage in chemoradiation-treated lung cancer patients 103
Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection 102
Assessing the value of neoadjuvant chemoradiotherapy and pathologic downstaging in the treatment of non-small cell lung cancer 100
A radiomic approach for adaptive radiotherapy in non-small cell lung cancer patients 98
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME). 89
Exploratory Radiomics for Predicting Adaptive Radiotherapy in Non-Small Cell Lung Cancer 85
Are We Ready for Histology-Driven Stereotactic Ablative Radiotherapy? 81
COVID-19 and radiation induced pneumonitis: Overlapping clinical features of different diseases 80
Doctor-in-the-Loop: An explainable, multi-view deep learning framework for predicting pathological response in non-small cell lung cancer 78
Precision radiotherapy by SPECT lung functional imaging in NSCLC 63
Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy: Real-world data from the E2-RADIatE OligoCare cohort 59
Efficacy of a Propolis-Based Syrup (FARINGEL) in Preventing Radiation-Induced Esophagitis in Locally Advanced Lung Cancer. 58
Empowering Hepatocellular Carcinoma Ablative Therapy: A Renaissance of Collaboration 56
Special Issue “Hepatobiliary and Pancreatic Cancers: Novel Strategies for of Diagnosis and Treatments” 55
Pancreatic cancer care: Lighting the way with the torch of staging laparoscopy and advanced imaging 55
Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis 55
Radiation therapy of breast cancer. Reasoned approach to a clinical case 55
Protective Role of Natural Compounds under Radiation-Induced Injury 54
Heterotopic hip ossification resection: monocentric experiences of associated factors, outcomes, and complications 52
Role of PSA levels and pathological stadiation before radiation therapy in predicting mp-MRI results in patients with prostate cancer recurrence after radical prostatectomy 50
Locally advanced NSCLC: how to improve disease control? 50
Local Control and Toxicity of Adaptive Radiotherapy Using Weekly CT Imaging: Results from the LARTIA Trial in Stage III NSCLC 49
The role of postoperative thoracic radiotherapy and prophylactic cranial irradiation in early stage small cell lung cancer: Patient selection among ESTRO experts. 48
Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines 48
The first survey on defensive medicine in radiation oncology 48
Stage III NSCLC treatment options: too many choices 47
Sequential chemo-hypofractionated RT versus concurrent standard CRT for locally advanced NSCLC: GRADE recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 47
Il trattamento radioterapico del Mesotelioma Pleurico 47
Evidence-Based Radiotherapy: “Hot Topics” 2010 NSCLC 47
Expression of the RNA-binding protein HuR and its clinical significance in human stage I and II lung adenocarcinoma. 46
MULTIMODALITY TREATMENT WITH RADIOCHEMOTHERAPY AND ERLOTINIB IN ADVANCED NSCLC (MARTE TRIAL). 46
RADIOCHEMOTHERAPY FOR LOCALLY-ADVANCED NSCLC: WHICH IS THE BEST ASSOCIATION? FROM CHEMOTHERAPY TO BIOLOGICAL TARGET IN 5 PHASES II TRIALS 46
Role of Postoperative Radiotherapy in the Management for Resected NSCLC – Decision Criteria in Clinical Routine Pre- and Post-LungART 45
Dose fractionation and biological optimization in lung cancer 45
Radiotherapy and vascular endothelial growth factor receptor-tyrosine kinase inhibitors in renal cancer 45
Totale 13.294
Salva come PNG Salva come JPEG
Categoria #
all - tutte 87.036
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.036
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022220 0 6 6 5 1 3 6 6 13 7 0 167
2022/2023172 1 1 2 8 8 1 24 6 74 0 38 9
2023/2024590 21 62 36 35 60 250 14 35 4 22 11 40
2024/20259.985 95 48 220 64 111 218 153 34 520 723 3.590 4.209
2025/20266.151 612 324 483 740 294 400 1.803 474 560 461 0 0
Totale 17.118